Postmarketing surveillance for drug safety: Surely we can do better

被引:21
作者
Griffin, MR
Stein, CM
Ray, WA
机构
[1] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Ctr Res & Educ Therapeut, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Ctr Res & Educ Therapeut, Nashville, TN 37232 USA
[3] Vet Affairs Tennessee Valley Healthcare Syst, Geriatr Res & Educ Clin Ctr, Nashville, TN USA
关键词
D O I
10.1016/j.clpt.2004.01.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:491 / 494
页数:4
相关论文
共 16 条
[1]   Peripheral neuropathy in patients treated with leflunomide [J].
Bonnel, RA ;
Graham, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (06) :580-585
[2]   Peripheral neuropathy: an unwanted effect of leflunomide? [J].
Carulli, MT ;
Davies, UM .
RHEUMATOLOGY, 2002, 41 (08) :952-953
[3]   Learning from the cerivastatin experience [J].
Farmer, JA .
LANCET, 2001, 358 (9291) :1383-1385
[4]  
Fries JF, 1999, NEW ENGL J MED, V341, P1397
[5]  
Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
[6]   Lessons from the glitazones: a story of drug development [J].
Gale, EAM .
LANCET, 2001, 357 (9271) :1870-1875
[7]   Systematic identification of drugs that cause birth defects - A new opportunity [J].
Mitchell, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2556-2559
[8]   Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association [J].
Nesto, RW ;
Bell, D ;
Bonow, RO ;
Fonseca, V ;
Grundy, SM ;
Horton, ES ;
Le Winter, M ;
Porte, D ;
Semenkovich, CF ;
Smith, S ;
Young, LH ;
Kahn, R .
CIRCULATION, 2003, 108 (23) :2941-2948
[9]   EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE [J].
RAY, WA ;
GRIFFIN, MR ;
AVORN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :2029-2032
[10]   High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic [J].
Schiff, GD ;
Keehr, LM ;
Sai, TT ;
Bult, J .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (08) :643-645